Menu
GeneBe

FUCA1

alpha-L-fucosidase 1, the group of Alpha-L-fucosidases

Basic information

Region (hg38): 1:23845076-23868290

Links

ENSG00000179163NCBI:2517OMIM:612280HGNC:4006Uniprot:P04066AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

  • fucosidosis (Definitive), mode of inheritance: AR
  • fucosidosis (Strong), mode of inheritance: AR
  • fucosidosis (Definitive), mode of inheritance: AR
  • fucosidosis (Strong), mode of inheritance: AR
  • fucosidosis (Supportive), mode of inheritance: AR
  • fucosidosis (Definitive), mode of inheritance: AR

Clinical Genomic Database

Source: CGD

ConditionInheritanceIntervention CategoriesIntervention/Rationale Manifestation CategoriesReferences
FucosidosisARGeneralGenetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testingBiochemical; Dermatologic; Musculoskeletal; Neurologic4172303; 4241464; 4247654; 5026163; 1214294; 4128078; 7460371; 6538300; 2903667; 3409541; 2642067; 2012122; 8719750; 9039984; 9762612; 10094192; 12408193; 17427030; 18504684

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the FUCA1 gene.

  • Fucosidosis (279 variants)
  • not provided (44 variants)
  • Inborn genetic diseases (16 variants)
  • not specified (8 variants)
  • Intellectual disability (2 variants)
  • FUCA1-related condition (2 variants)
  • Abnormality of the nervous system (1 variants)
  • FU1/FU2 POLYMORPHISM (1 variants)

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the FUCA1 gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
1
clinvar
64
clinvar
65
missense
1
clinvar
6
clinvar
109
clinvar
7
clinvar
5
clinvar
128
nonsense
17
clinvar
4
clinvar
1
clinvar
22
start loss
1
clinvar
1
frameshift
8
clinvar
3
clinvar
11
inframe indel
3
clinvar
3
splice donor/acceptor (+/-2bp)
1
clinvar
4
clinvar
5
splice region
10
8
18
non coding
7
clinvar
31
clinvar
11
clinvar
49
Total 27 17 122 102 16

Highest pathogenic variant AF is 0.0000132

Variants in FUCA1

This is a list of pathogenic ClinVar variants found in the FUCA1 region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
1-23845171-A-T Fucosidosis Uncertain significance (Jan 13, 2018)296880
1-23845188-T-C Fucosidosis Uncertain significance (Jun 14, 2016)296881
1-23845272-TCCTGC-T Fucosidosis Uncertain significance (Jun 14, 2016)296882
1-23845373-G-T Fucosidosis Uncertain significance (Jan 12, 2018)875348
1-23845429-G-T Fucosidosis Uncertain significance (Jan 13, 2018)296883
1-23845445-A-G Fucosidosis Uncertain significance (Jan 13, 2018)296884
1-23845618-A-G Fucosidosis Uncertain significance (Jan 13, 2018)875404
1-23845724-T-A Fucosidosis Uncertain significance (May 03, 2021)1351082
1-23845730-C-G Fucosidosis Likely benign (Nov 23, 2021)1588988
1-23845732-G-T Fucosidosis Uncertain significance (Jul 05, 2022)1389947
1-23845738-T-C Fucosidosis • Inborn genetic diseases Uncertain significance (Dec 18, 2023)1408507
1-23845756-C-T Fucosidosis Uncertain significance (Aug 06, 2022)1495120
1-23845757-G-A Fucosidosis Likely benign (Dec 14, 2023)1144782
1-23845769-G-T Fucosidosis Likely benign (Jan 29, 2024)733786
1-23845781-G-C Fucosidosis Likely benign (Nov 25, 2023)1370016
1-23845790-G-A Fucosidosis Likely benign (Nov 27, 2023)754188
1-23845793-G-A Fucosidosis Likely benign (Mar 18, 2023)2742157
1-23845796-G-C Fucosidosis Likely benign (Feb 06, 2023)2024030
1-23845807-C-G Fucosidosis Uncertain significance (Jun 03, 2021)1515477
1-23845814-TGTGGACCACTTCA-T Fucosidosis Pathogenic/Likely pathogenic (Jan 12, 2024)2445830
1-23845821-C-T Fucosidosis Uncertain significance (Mar 22, 2019)859832
1-23845830-T-C Fucosidosis Uncertain significance (Sep 12, 2022)2079874
1-23845830-T-TA not specified • Fucosidosis Conflicting classifications of pathogenicity (Oct 06, 2023)1328977
1-23845835-T-C Fucosidosis Likely benign (Nov 03, 2023)2692952
1-23845837-G-A Fucosidosis Pathogenic (Jan 19, 2024)681

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
FUCA1protein_codingprotein_codingENST00000374479 823218
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
2.70e-80.9111257170311257480.000123
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense0.8452182560.8510.00001293003
Missense in Polyphen8397.8720.848041199
Synonymous0.206981010.9740.00000514896
Loss of Function1.781625.70.6210.00000120261

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.0002350.000235
Ashkenazi Jewish0.00009930.0000992
East Asian0.0001630.000163
Finnish0.000.00
European (Non-Finnish)0.0001240.000123
Middle Eastern0.0001630.000163
South Asian0.0001960.000196
Other0.000.00

dbNSFP

Source: dbNSFP

Function
FUNCTION: Alpha-L-fucosidase is responsible for hydrolyzing the alpha-1,6-linked fucose joined to the reducing-end N- acetylglucosamine of the carbohydrate moieties of glycoproteins.;
Disease
DISEASE: Fucosidosis (FUCA1D) [MIM:230000]: An autosomal recessive lysosomal storage disease characterized by accumulation of fucose- containing glycolipids and glycoproteins in various tissues. Clinical signs include facial dysmorphism, dysostosis multiplex, moderate hepatomegaly, severe intellectual deficit, deafness, and according to age, angiokeratomas. {ECO:0000269|PubMed:7874128, ECO:0000269|PubMed:8504303, ECO:0000269|PubMed:9762612}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Pathway
Lysosome - Homo sapiens (human);Other glycan degradation - Homo sapiens (human);Neutrophil degranulation;Post-translational protein modification;Reactions specific to the complex N-glycan synthesis pathway;N-glycan antennae elongation in the medial/trans-Golgi;Metabolism of proteins;Innate Immune System;Immune System;Transport to the Golgi and subsequent modification;Asparagine N-linked glycosylation (Consensus)

Recessive Scores

pRec
0.293

Intolerance Scores

loftool
0.869
rvis_EVS
0.66
rvis_percentile_EVS
84.55

Haploinsufficiency Scores

pHI
0.0887
hipred
Y
hipred_score
0.564
ghis
0.382

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
N
essential_gene_gene_trap
N
gene_indispensability_pred
E
gene_indispensability_score
0.861

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumHigh
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Fuca1
Phenotype
nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); renal/urinary system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); pigmentation phenotype; homeostasis/metabolism phenotype; cellular phenotype;

Gene ontology

Biological process
fucose metabolic process;glycosaminoglycan catabolic process;glycoside catabolic process;glycolipid catabolic process;neutrophil degranulation
Cellular component
extracellular region;cytoplasm;lysosome;azurophil granule lumen;lysosomal lumen;extracellular exosome
Molecular function
alpha-L-fucosidase activity